"The revelation about GLP-1 medication is that it really works against all major substances, and it works uniformly, not because it acts against alcohol or opioids or nicotine specifically, but because it is likely acting against the craving itself
Its GLP-1 receptor agonist portfolio, anchored by semaglutide in its injectable form (Ozempic for diabetes, Wegovy for obesity) and oral form (Rybelsus), generated approximately USD 26 billion in combined sales in 2024, making semaglutide the world's highest-revenue drug
Eyelid Surgery (Blepharoplasty) Weight loss often accelerates the hollowing of the under-eye area and can contribute to increased upper eyelid exposure, making the eyes look tired, sunken, or aged
Makary has indicated that the FDA will take an aggressive enforcement stance on GLP-1 compounded products as well as action on misleading advertising for such products